Salier J P, Sesboüé R, Martin-Mondière C, Daveau M, Cesaro P, Cavelier B, Coquerel A, Legrand L, Goust J M, Degos J D
J Clin Invest. 1986 Aug;78(2):533-8. doi: 10.1172/JCI112605.
In some Caucasian populations, multiple sclerosis (MS) susceptibility has been independently related to given alleles of HLA or Gm systems that respectively code for major histocompatibility complex class I and II antigens or immunoglobulin G heavy chains. Whether given combinations of alleles at both series of loci simultaneously influence MS susceptibility and/or severity was investigated by comparing 147 French MS patients and 226 geographically-matched healthy controls. The G2m(-23)/HLA-B35 phenotype and G1m(-1)/HLA-B7(-)/HLA-DR2 phenotype were respectively associated with significant protection against (relative risk = 0.05) and susceptibility to (relative risk = 4.3) MS. When considering MS severity, the presence of HLA-B7 antigen correlated with a more severe disease in Gm1/Gm3 heterozygous patients, but not in Gm3/Gm3 homozygous patients. Conversely, an HLA-B12-associated milder disease was restricted to Gm3/Gm3 homozygotes. These results demonstrate the combined influence on MS of genetic loci that are unlinked but immune response-associated. Combined Gm and HLA typing is very likely able to serve as a prognostic indicator in this disease.
在一些高加索人群中,多发性硬化症(MS)易感性分别与HLA或Gm系统的特定等位基因独立相关,这些等位基因分别编码主要组织相容性复合体I类和II类抗原或免疫球蛋白G重链。通过比较147名法国MS患者和226名地理匹配的健康对照,研究了这两个系列基因座上特定等位基因组合是否同时影响MS易感性和/或严重程度。G2m(-23)/HLA-B35表型和G1m(-1)/HLA-B7(-)/HLA-DR2表型分别与对MS的显著保护作用(相对风险=0.05)和易感性(相对风险=4.3)相关。在考虑MS严重程度时,HLA-B7抗原的存在与Gm1/Gm3杂合患者中更严重的疾病相关,但在Gm3/Gm3纯合患者中则不然。相反,与HLA-B12相关的较轻疾病仅限于Gm3/Gm3纯合子。这些结果证明了与免疫反应相关但未连锁的基因座对MS的联合影响。联合Gm和HLA分型很可能能够作为这种疾病的预后指标。